FDA Clinical Investigator Training Course (CITC) 2024 – Day Two – Session One
![](https://i.ytimg.com/vi/TAhh02hYhE8/mqdefault.jpg)
2:23:52
FDA Clinical Investigator Training Course (CITC) 2024 – Day Two – Session Two
![](https://i.ytimg.com/vi/zz358OaQkeI/mqdefault.jpg)
56:31
CMC Considerations for Biotechnology Product Development: A Regulatory Perspective
![](https://i.ytimg.com/vi/8HAPW7clEqQ/mqdefault.jpg)
17:02
CDER BIMO: Electronic Submission Requirements for New Drug and Biologic Licensing Applications
![](https://i.ytimg.com/vi/3-AY3XEIt7E/mqdefault.jpg)
20:43
VIRTUAL PRESS CONFERENCE: FDA’s Proposed Rule on Reducing Nicotine Levels – 1/15/2025
![](https://i.ytimg.com/vi/Ul-2Tyz34tc/mqdefault.jpg)
5:01
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic aci...
![](https://i.ytimg.com/vi/ARA-2wP6144/mqdefault.jpg)
1:42:25
FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session Two
![](https://i.ytimg.com/vi/DpL5se094EY/mqdefault.jpg)
1:04:05
Cervical Cancer Treatment Innovation: A Collaborative Discussion
![](https://i.ytimg.com/vi/ih2FFce8Mks/mqdefault.jpg)
0:24